Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 24 | 28 | +4 |
| Shares | 276.4K | 330.1K | +53.7K (+19.4%) |
| Value | $254.1K | $617.7K | +$363.6K (+143.1%) |
New holders (5)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 22,594 | $42.7K | 0.00% |
| Two Sigma Securities, LLC | 12,560 | $23.7K | 0.00% |
| HRT Financial LP | 10,784 | $20.0K | 0.00% |
| Citigroup Inc | 1,260 | $2.38K | 0.00% |
| Rockefeller Capital Management L.P. | 500 | $945 | 0.00% |
Sold out (1)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Raymond James Financial Inc | 320 | $285 |